Researchers at Stanford University have achieved a notable breakthrough in Type 1 diabetes research, demonstrating accomplished disease prevention and reversal in mice using a novel “hybrid” therapy. The approach, detailed in recent findings, combines immune cells from donor and recipient animals – crucially, without the need for immunosuppressant drugs that frequently enough complicate transplant procedures. This innovative technique offers a promising new avenue for potential treatments, not only for Type 1 diabetes but also for improving outcomes in organ transplantation where immune rejection remains a major hurdle.
STANFORD / LONDON (IT BOLTWISE) – A novel hybrid therapy has shown promising results in treating Type 1 diabetes in mice. The method combines immune cells from donor and recipient animals, enabling a form of harmonization without the need for immunosuppressant drugs. This development could have implications not only for diabetes patients but also for organ transplantation.
Heutige Tagesdeals bei Amazon! ˗ˋˏ$ˎˊ˗
A groundbreaking hybrid therapy has demonstrated remarkable success in treating Type 1 diabetes in mice, according to researchers at the Stanford School of Medicine. The innovative approach combines immune cells from both donor and recipient animals, achieving cellular harmony and eliminating the need for immunosuppressant medications. This therapy holds potential not only for diabetes treatment but also for broader applications in organ transplantation.
Type 1 diabetes is an autoimmune condition where the body’s immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. While transplanting healthy donor islets is a potential treatment, there’s a significant risk of the recipient’s immune system rejecting the new cells. This new therapy addresses this challenge by subtly “resetting” the mice’s immune systems to better accept the transplanted tissue.
The researchers prepared the mice’s immune systems using a combination of an immune system inhibitor, a low dose of radiation, and selected antibodies. They then combined blood stem cells and islet cells from another animal. This process prevented the transplanted cells from being recognized as foreign invaders, allowing the immune system to resume normal function without destroying the critical tissue.
The results are encouraging: the treated mice did not develop diabetes, and importantly, did not experience graft-versus-host disease, a common complication of transplantation. These findings offer hope that the method could be applicable to humans. However, challenges remain, including the availability of donor cells and determining the optimal number of cells needed for successful treatment. Researchers are currently working to improve the survival rate of donated cells or to produce them in the lab from human pluripotent stem cells.
Amazon-Kreditkarte ohne Jahresgebühr mit 2.000 Euro Verfügungsrahmen bestellen!
Bestseller Nr. 1 ᵃ⤻ᶻ «KI Gadgets»
Bestseller Nr. 2 ᵃ⤻ᶻ «KI Gadgets»
Bestseller Nr. 3 ᵃ⤻ᶻ «KI Gadgets»
Bestseller Nr. 4 ᵃ⤻ᶻ «KI Gadgets»
Bestseller Nr. 5 ᵃ⤻ᶻ «KI Gadgets»
News Espresso» mit den besten KI-News des letzten Tages gratis per eMail – ohne Werbung:
Hier kostenlos eintragen!
This article is for informational purposes only and does not constitute medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
